Disentangling the interactions between nasopharyngeal and gut microbiome and their involvement in the modulation of COVID-19 infection

ABSTRACT The human organism is inhabited by trillions of microorganisms, known as microbiota, which are considered to exploit a pivotal role in the regulation of host health and immunity. Recent investigations have suggested a relationship between the composition of the human microbiota and COVID-19 infection, highlighting a possible role of bacterial communities in the modulation of the disease severity. In this study, we performed a shotgun metagenomics analysis to explore and compare the nasopharyngeal microbiota of 38 hospitalized Italian patients with and without COVID-19 infection during the third and fourth pandemic waves. In detail, the metagenomic analysis combined with specific correlation analyses suggested a positive association of several microbial species, such as S. parasanguinis and P. melaninogenica, with the severity of COVID-19 infection. Furthermore, the comparison of the microbiota composition between the nasopharyngeal and their respective fecal samples highlighted an association between these different compartments represented by a sharing of several bacterial species. Additionally, lipidomic and deep-shotgun functional analyses of the fecal samples suggested a metabolic impact of the microbiome on the host’s immune response, indicating the presence of key metabolic compounds in COVID-19 patients, such as lipid oxidation end products, potentially related to the inflammatory state. Conversely, the patients without COVID-19 displayed enzymatic patterns associated with the biosynthesis and degradation of specific compounds like lysine (synthesis) and phenylalanine (degradation) that could positively impact disease severity and contribute to modulating COVID-19 infection. IMPORTANCE The human microbiota is reported to play a major role in the regulation of host health and immunity, suggesting a possible impact on the severity of COVID-19 disease. This preliminary study investigated the possible correlation between nasopharyngeal microbiota and COVID-19 infection. In detail, the analysis of the nasopharyngeal microbiota of hospitalized Italian patients with and without COVID-19 infection suggested a positive association of several microbial species with the severity of the disease and highlighted a sharing of several bacteria species with the respective fecal samples. Moreover, the metabolic analyses suggested a possible impact of the microbiome on the host's immune response and the disease severity. The human microbiota is reported to play a major role in the regulation of host health and immunity, suggesting a possible impact on the severity of COVID-19 disease. This preliminary study investigated the possible correlation between nasopharyngeal microbiota and COVID-19 infection. In detail, the analysis of the nasopharyngeal microbiota of hospitalized Italian patients with and without COVID-19 infection suggested a positive association of several microbial species with the severity of the disease and highlighted a sharing of several bacteria species with the respective fecal samples. Moreover, the metabolic analyses suggested a possible impact of the microbiome on the host's immune response and the disease severity.

[1]  E. Mehraeen,et al.  Gut microbiota and COVID‐19: A systematic review , 2023, Health science reports.

[2]  S. Candel,et al.  The nasopharyngeal microbiome in COVID-19 , 2023, Emerging microbes & infections.

[3]  H. Xiang,et al.  Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential , 2022, World journal of gastroenterology.

[4]  A. Buzoianu,et al.  Gastrointestinal microbiota: A predictor of COVID-19 severity? , 2022, World journal of gastroenterology.

[5]  Upendra K. Kar,et al.  Lipidomic signatures align with inflammatory patterns and outcomes in critical illness , 2022, Nature communications.

[6]  C. Trautwein,et al.  The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease , 2022, Frontiers in Cellular and Infection Microbiology.

[7]  M. Joshi,et al.  Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals , 2022, Microbial Pathogenesis.

[8]  F. Turroni,et al.  Untangling the link between the human gut microbiota composition and the severity of the symptoms of the COVID‐19 infection , 2022, Environmental microbiology.

[9]  T. Miyoshi‐Akiyama,et al.  Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications , 2022, Gastroenterology.

[10]  A. Manges,et al.  Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity , 2022, medRxiv.

[11]  D. Raoult,et al.  Profile of the Nasopharyngeal Microbiota Affecting the Clinical Course in COVID-19 Patients , 2022, Frontiers in Microbiology.

[12]  A. Weisz,et al.  NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy , 2022, Microbial Pathogenesis.

[13]  E. Gratacós,et al.  Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection , 2022, Scientific Reports.

[14]  Yunfeng Yang,et al.  SARS‐CoV‐2 triggered oxidative stress and abnormal energy metabolism in gut microbiota , 2022, MedComm.

[15]  R. Vernal,et al.  Oral-Gut-Brain Axis in Experimental Models of Periodontitis: Associating Gut Dysbiosis With Neurodegenerative Diseases , 2021, Frontiers in Aging.

[16]  J. Buer,et al.  A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19 , 2021, Frontiers in Cellular and Infection Microbiology.

[17]  M. Cominetti,et al.  Phenylalanine and COVID-19: Tracking disease severity markers , 2021, International Immunopharmacology.

[18]  Wen-Chi Su,et al.  Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection , 2021, Viruses.

[19]  F. Turroni,et al.  METAnnotatorX2: a Comprehensive Tool for Deep and Shallow Metagenomic Data Set Analyses , 2021, mSystems.

[20]  M. Shi,et al.  Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19 , 2021, Synthetic and Systems Biotechnology.

[21]  R. Boorstein,et al.  Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights , 2021, medRxiv.

[22]  Kang Zhang,et al.  COVID-19 in early 2021: current status and looking forward , 2021, Signal Transduction and Targeted Therapy.

[23]  Tao Zhang,et al.  Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults , 2021, Communications biology.

[24]  Jia Li,et al.  Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19. , 2021, Annals of palliative medicine.

[25]  S. Bernasconi,et al.  Amoxicillin-Clavulanic Acid Resistance in the Genus Bifidobacterium , 2021, Applied and Environmental Microbiology.

[26]  Timothy L. Tickle,et al.  Multivariable association discovery in population-scale meta-omics studies , 2021, bioRxiv.

[27]  K. Chow,et al.  Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 , 2021, Gut.

[28]  Upendra K. Kar,et al.  Lipidomic Signatures Align with Inflammatory Patterns and Outcomes in Critical Illness , 2021, Nature Communications.

[29]  M. López-Pérez,et al.  Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19 , 2020, bioRxiv.

[30]  D. Crossman,et al.  Strain Tracking to Identify Individualized Patterns of Microbial Strain Stability in the Developing Infant Gut Ecosystem , 2020, Frontiers in Pediatrics.

[31]  J. Baizabal-Carvallo Gut microbiota: a potential therapeutic target for Parkinson’s disease , 2020, Neural regeneration research.

[32]  W. Giannobile,et al.  The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis , 2020, Cell.

[33]  Gek Huey Chua,et al.  Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis , 2020, Cell Metabolism.

[34]  Lanjuan Li,et al.  Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  S. Ng,et al.  Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization , 2020, Gastroenterology.

[36]  Huanhuan Gao,et al.  Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.

[37]  Rebecca L. Moore,et al.  Tracing mother-infant transmission of bacteriophages by means of a novel analytical tool for shotgun metagenomic datasets: METAnnotatorX , 2018, Microbiome.

[38]  Emmanuel Paradis,et al.  ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R , 2018, Bioinform..

[39]  T. Spector,et al.  Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.

[40]  W. D. de Vos,et al.  The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota , 2017, Microbiology and Molecular Biology Reviews.

[41]  Lynn Vanhaecke,et al.  Holistic Lipidomics of the Human Gut Phenotype Using Validated Ultra-High-Performance Liquid Chromatography Coupled to Hybrid Orbitrap Mass Spectrometry. , 2017, Analytical chemistry.

[42]  Christopher Wilks,et al.  Scaling read aligners to hundreds of threads on general-purpose processors , 2017, bioRxiv.

[43]  G. Poli,et al.  Lipid Oxidation Products in the Pathogenesis of Inflammation-related Gut Diseases. , 2017, Current medicinal chemistry.

[44]  Suzanne M. Paley,et al.  The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases , 2015, Nucleic Acids Res..

[45]  Ying Chen,et al.  High speed BLASTN: an accelerated MegaBLAST search tool , 2015, Nucleic acids research.

[46]  W. Rizzo Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function. , 2014, Biochimica et biophysica acta.

[47]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[48]  Yongan Zhao,et al.  RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data , 2011, Bioinform..

[49]  Haixu Tang,et al.  RAPSearch: a fast protein similarity search tool for short reads , 2011, BMC Bioinformatics.

[50]  L. Huc,et al.  Chemistry and biochemistry of lipid peroxidation products , 2010, Free radical research.

[51]  B. Fauconneau,et al.  Plasmalogen degradation by oxidative stress: production and disappearance of specific fatty aldehydes and fatty alpha-hydroxyaldehydes. , 2001, Free radical biology & medicine.

[52]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[53]  R. Zoeller,et al.  Isolation of Animal Cell Mutants Defective in Long-chain Fatty Aldehyde Dehydrogenase* , 1997, The Journal of Biological Chemistry.

[54]  Haixu Tang,et al.  RAPSearch 2 : a fast and memory-efficient protein similarity search tool for next-generation sequencing data , 2011 .

[55]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.